Greece Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Greece Pharmaceuticals and Healthcare Report

Greece Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Greece Pharmaceuticals and Healthcare Report
Published Aug 13, 2016
89 pages — Published Aug 13, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In BMI s Q--- Pharmaceutical Risk/Reward Index (RRI) Greece is ranked third out of the -- markets in the Central and Eastern European (CEE) matrix with a significantly increased score of --.- compared with the previous quarter (--.-). This increase is a result of the country s economy returning to modest growth following a large recession in ----. ...This increase is a result of the country s economy returning to modest growth following a large recession in ----. However, Greece continues to experience a high level of financial and political uncertainty as the new government faces mounting pressure to balance the increasingly urgent demands of both its international creditors in addition to the Greek electorate. The Greek pharmaceutical market has been characterised of late by mandated price reductions, state intervention in the trade of ...However, Greece continues to experience a high level of financial and political uncertainty as the new government faces mounting pressure to balance the increasingly urgent demands of both its international creditors in addition to the Greek electorate. The Greek pharmaceutical market has been characterised of late by mandated price reductions, state intervention in the trade of

...An ageing population that will require advanced pharmaceuticals. Greece still has one of the highest per capita pharmaceutical spending in Europe, and the highest in Central and Eastern Europe. ...An ageing population that will require advanced pharmaceuticals. Greece still has one of the highest per capita pharmaceutical spending in Europe, and the highest in Central and Eastern Europe. Weaknesses Major price cuts to medicines since ----. ...Low levels of foreign investment, owing to uncertainty associated with the pricing- and-reimbursement policy and delicate political and economic environment.

...In July ----, the Ministry of Health (MoH) began the payment of overdue hospital medicine debts to suppliers, starting with a EUR---mn (USD---mn) grant. According to the MoH, EUR-.-bn (USD-.--bn) will be paid off by the end of ----. ...According to the MoH, EUR-.-bn (USD-.--bn) will be paid off by the end of ----. The Southern Europe countries of Greece, Cyprus, Portugal, Italy and Malta announced in July ---- that they had set up a technical committee to exchange expertise with respect to health technology assessment (HTA), medicine pricing and negotiation with the pharmaceutical industry. In June ----, the Greek Ministry of Health met representatives of WHO to discuss the design implementation of healthcare reforms. ...

  
Source:
Document ID
1748-1902
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Greece Pharmaceuticals and Healthcare Report" Aug 13, 2016. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Greece-Pharmaceuticals-and-Healthcare-Report-2026-289>
  
APA:
Business Monitor International - Industry Reports. (2016). Greece Pharmaceuticals and Healthcare Report Aug 13, 2016. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Greece-Pharmaceuticals-and-Healthcare-Report-2026-289>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.